Equillium (NASDAQ:EQ) Price Target Cut to $5.50

Equillium (NASDAQ:EQ – Get Rating) had its price target lowered by HC Wainwright from $20.00 to $5.50 in a research report sent to investors on Monday, The Fly reports. Other analysts also recently issued reports about the company. SVB Leerink decreased their price objective on Equillium from $12.00 to $7.00 and set an outperform rating […]

Related Keywords

Stifel Nicolaus ,Daniel Mark Bradbury ,Dimensional Fund Advisors ,Equillium Company Profile ,Wealth Concepts ,Capital Cs Group ,Equillium Inc ,Renaissance Technologies ,Get Rating ,Trading Down ,Fund Advisors ,Jane Street Group ,Equillium Daily ,Equillium ,Nasdaq Eq ,Eq ,Medical ,Lower Price Target ,Hc Wainwright ,